pragma.vision Technology observatory & strategic foresight

Verification register Bio, Health & Neuro

Readiness verdict

Motif Neurotech DOT (XCS System)

A dated reading of what is claimed, reported, and independently verified in the current evidence.

As of
2026-08-20
Revision
1
Method
v1.3.0

Current reading

Readiness band and full integer triple

AI-assisted assembly · derived results

Readiness band

Emerging

Primary summary from verified readiness

Confidence
81% · stale
Computed at
2026-08-20T10:52:55.692901+00:00
Claimed
35

Public ambition and stated capability

Reported
31

Observed practitioner reporting

Verified
22

Independently supported evidence

Gap
+13

Claimed leads verified

Evidence strength Strong

Decision

What the current evidence supports

Human editorial judgment · 2026-08-20

Track; not yet

Why
Genuine regulatory milestone (FDA IDE, Apr 2026) and credible funding ($18.75M Series A; ARPA-H EVIDENT up to $139.4M program), but it is a first-in-human feasibility implant with zero human efficacy evidence — too early for any adoption, worth tracking as a frontier therapeutic-BCI signal.
Next
Watch for RESONATE 12-month safety readout and any first efficacy signal; monitor ARPA-H EVIDENT milestone reporting for response-data outcomes.

Constraints

Blockers

No named blocker is present in the current public projection.

Evidence summary

Derived counts

AI-assisted assembly

Total
13
Tier 1
4
Tier 2
9
Tier 3
0
Supports
8
Contradicts
4
Context
1
Latest observed
2026-07-20

Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.

Publication record

Revisions

Initial public reading

  1. 2026-07-19 Reading moved from emerging to emerging.

Your opinion

Tell us anything.

What works, what doesn't, what's missing — especially about our watches, lenses, and the register itself. Anonymous is fine; leave an email if you'd like a reply.